Fascioscapulohumeral Muscular Dystrophy Type 2

Explore clinical trials studying Fascioscapulohumeral Muscular Dystrophy Type 2. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Fascioscapulohumeral Muscular Dystrophy Type 2 trial results

Recruiting

NCT07038200

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, FSH Muscular Dystrophy, FSHD, +25 more
Locations: University of California Irvine Orange, California, United States

Stanford University Palo Alto, California, United States

University of Colorado Denver, Colorado, United States

University of Florida Gainesville, Florida, United States

View all 46 locations

Completed

NCT05747924

Conditions: Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
Locations: University of California Los Angeles Los Angeles, California, United States

Stanford University Palo Alto, California, United States

University of California San Diego San Diego, California, United States

University of Colorado Denver, Colorado, United States

View all 17 locations

Active, Not Recruiting

NCT06547216

Conditions: Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
Locations: University of California Los Angeles Los Angeles, California, United States

Stanford University Palo Alto, California, United States

University of California San Diego San Diego, California, United States

University of Colorado Denver, Colorado, United States

View all 17 locations